The evidence here is genuinely mixed and modest, not a settled benefit.

A meta-analysis of 23 studies found a small strength improvement, roughly 5 percent, in hormone therapy users, and one well-designed year-long trial found meaningful gains in muscle size and jumping power, especially when combined with high-impact exercise. But the largest, most rigorous review of lean muscle mass specifically found no significant effect and concluded other approaches should be explored instead. Hormone therapy is not an established treatment for sarcopenia, and there is no trial evidence at all that it prevents frailty. Resistance training remains the intervention with the strongest evidence for preserving muscle.

What to know about this answer

The field split here is real and centers on how much weight to give small, encouraging RCT and twin-study signals against the largest, most rigorous meta-analysis, which found no effect on lean mass at all.

What the research shows, and which source each finding rests on

Strength meta-analysis of 23 studies found a small beneficial effect (effect size 0.23, about 5% greater strength in hormone therapy users).

Muscle mass systematic review and meta-analysis of 12 RCTs (4,474 women) found no significant effect on lean body mass (0.06 kg less loss than placebo, p=0.26, low GRADE quality); the authors concluded interventions other than hormone therapy should be explored.

A 12-month randomized placebo-controlled trial (80 women) found hormone therapy alone increased quadriceps lean cross-sectional area 6.3% and vertical jump 6.8%; hormone therapy plus high-impact exercise increased knee extension torque 8.3% and vertical jump 17.2% versus controls, who gained intramuscular fat.

In monozygotic twin pairs discordant for hormone therapy use (mean use 6.9 years), the twin using hormone therapy had 7% faster maximal walking speed and 16% greater muscle power, with less fat infiltration.

Frailty is a validated, outcome-predicting syndrome in postmenopausal women, but there is no randomized trial evidence that hormone therapy prevents frailty.

Where the real disagreement is

Each position is shown with its own sources. A position listed here is not necessarily the accepted view.

Meaningful muscle benefit

field clinicians including Dr. Vonda Wright, and with more nuance, Dr. Mary Claire Haver

Estrogen receptors exist on muscle and satellite cells; the strength meta-analysis found a real if modest effect, a year-long randomized trial showed measurable gains in muscle size and power, and discordant-twin data, which controls for genetics and much of lifestyle, showed faster walking speed and greater muscle power in the twin who used hormone therapy.

Unproven for muscle mass specifically

the meta-analytic bottom line, echoed by exercise scientists such as Dr. Stacy Sims

The only modern systematic meta-analysis of lean body mass, pooling 12 randomized trials, found no significant effect and concluded that other interventions should be explored; this camp's strongest recommendation is to train for the stimulus, through resistance and high-intensity exercise, rather than expect hormones to do that work.

What would settle it: An adequately powered randomized trial of modern hormone therapy with muscle mass, strength, power, and physical function as primary endpoints, including arms with and without resistance training.

What is really going on here

  1. Am I being quoted a relative or absolute change - what does a finding like '5 percent greater strength' actually mean in real terms?

Questions for your doctor

  1. Is muscle preservation being offered as a proven benefit of hormone therapy, or as one plausible but unproven effect?
  2. What does the evidence say about combining hormone therapy with resistance training specifically?
  3. Should I prioritize strength training regardless of my hormone therapy decision?

Questions with no answer yet

Does hormone therapy meaningfully help muscle strength and power even without a significant effect on muscle mass itself, and if so, through what mechanism?

Partly studied

What is known: A meta-analysis found a small strength benefit and a separate meta-analysis found no significant effect on lean body mass, meaning strength and mass do not necessarily move together in this evidence base. Why a real strength signal might exist without a corresponding mass signal has not been mechanistically investigated.

What would test it: An adequately powered randomized trial of modern hormone therapy with muscle mass, strength, power, and physical function as separate, prespecified primary endpoints, allowing the two kinds of outcome to be compared directly.

Does combining hormone therapy with resistance training produce a genuinely larger effect than resistance training alone, or would the training itself explain most of the benefit seen in the one strongest trial?

Not directly studied yet

No research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.

What is known: The single best available randomized trial found larger gains in the group combining hormone therapy with high-impact exercise than in the hormone-alone group, but no trial has included a resistance-training-alone arm alongside a hormone-therapy-alone arm and a combined arm, so it is not possible to cleanly separate how much of the combined benefit comes from the hormones versus the exercise.

What would test it: A three-arm or four-arm trial including resistance training alone, hormone therapy alone, the combination, and a control, with muscle mass, strength, and power as primary endpoints in peri or early postmenopausal women.

Sources

  1. 1.Hormone therapy and skeletal muscle strength: a meta-analysis.Greising SM, et al. Hormone therapy and skeletal muscle strength: a meta-analysis. J Gerontol A Biol Sci Med Sci. 2009;64(10):1071-81. · Systematic review or guideline
  2. 2.Association Between Hormone Therapy and Muscle Mass in Postmenopausal Women: A Systematic Review and Meta-analysis.Javed AA, et al. Association between hormone therapy and muscle mass in postmenopausal women: a systematic review and meta-analysis. JAMA Netw Open. 2019;2(8):e1910154. · Systematic review or guideline
  3. 3.Effects of hormone replacement therapy and high-impact physical exercise on skeletal muscle in post-menopausal women: a randomized placebo-controlled study.Sipila S, et al. Effects of hormone replacement therapy and high-impact physical exercise on skeletal muscle in post-menopausal women: a randomized placebo-controlled study. Clin Sci (Lond). 2001;101(2):147-57. · Randomised trial
  4. 4.Postmenopausal hormone replacement therapy modifies skeletal muscle composition and function: a study with monozygotic twin pairs.Ronkainen PH, et al. Postmenopausal hormone replacement therapy modifies skeletal muscle composition and function: a study with monozygotic twin pairs. J Appl Physiol (1985). 2009;107(1):25-33. · Observational study
  5. 5.Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study.Woods NF, et al. Frailty: emergence and consequences in women aged 65 and older in the WHI Observational Study. J Am Geriatr Soc. 2005;53(8):1321-30. · Observational study

The letter grades the type of study behind a claim, not the answer itself.

This page is general information based on published research and public sources. It is not medical advice and not a personal assessment, and it does not replace a conversation with your doctor. Peritale is a wellness product, not a medical device, and is not intended to diagnose, treat, cure or prevent any disease. For any medical question, speak with a licensed clinician.

You are not imagining it

In about seven minutes on your phone, Peritale reads five signal systems and maps your symptoms, so you can see that what you feel is real, follow your hormonal transition over time, and walk into your doctor ready to ask for the care you deserve. Your first check is free, no credit card.

Start Free Mapping

Related questions